Management of the long-term intervention with pravastatin in ischaemic disease (LIPID) study after the scandinavian simvastatin survival study (4S)

This publication has 24 references indexed in Scilit:

• Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens
  The American Journal of Cardiology, 1995
• Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin
  The Lancet, 1994
• Cholesterol lowering and mortality: the importance of considering initial level of risk.
  BMJ, 1993
• Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.
  Heart, 1993
• Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
  BMJ, 1992
• Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
  The American Journal of Cardiology, 1991
• Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
  BMJ, 1990
• Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease
  New England Journal of Medicine, 1990
• INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES
  The Lancet, 1989
• Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register.
  Circulation, 1983